GS0421: Providing information to patients and healthcare providers about pharmaceutical drug development, namely, formulation technology which is intended to deter the abusive use of prescription painkillers
Case File Event Statements
4/22/2019 - 5 years ago
17 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDType:MAB6
4/22/2019 - 5 years ago
16 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
9/18/2018 - 6 years ago
15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
7/24/2018 - 6 years ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
7/24/2018 - 6 years ago
13 - PUBLISHED FOR OPPOSITIONType:PUBO
7/4/2018 - 6 years ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
6/11/2018 - 6 years ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
6/11/2018 - 6 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
6/11/2018 - 6 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
6/5/2018 - 6 years ago
8 - ASSIGNED TO LIEType:ALIE
5/29/2018 - 6 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
5/10/2018 - 6 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
5/10/2018 - 6 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
5/10/2018 - 6 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
5/4/2018 - 6 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
2/2/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS